1800 500 258

Latest news

Find the latest news and information from BCNA

10 year aromatase inhibitor treatment may help stop recurrence

Latest research 04 Jul 2016

10 year aromatase inhibitor treatment may help stop recurrence

Previous research has shown that taking tamoxifen for ten years provides further protection against breast cancer recurring (coming back) and is better for some women than five years. Another large international clinical trial has now confirmed that ten years of an aromatase inhibitor may be better than five years for some women. Results from this research were presented at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Read more